Working with Trauma in Alzheimer’s & Dementia
Untreated and unresolved trauma is now considered to be a risk factor and contributor to Alzheimer’s dementia. Trauma can be defined as any event that alters how we process, react …
Why I’m Excited About Aducanumab (Aduhelm)!
In this episode of Evolving Past Alzheimer’s, Dr. Nate Bergman quickly summarizes the story up the FDA’s recent “accelerated approval” of Biogen’s – Aducanumab (brand named, Aduhelm). He ends off …
